Jan 30, 2023 Research News LJI scientists uncover the structure and function of Inmazeb, the first FDA-approved drug for Ebola virus infection LA JOLLA, CA—Scientists at La Jolla Institute for Immunology (LJI) have uncovered the structure and function of the first FDA-approved Read More
Jan 18, 2023 Institute News Shane Crotty receives AAI-BioLegend Herzenberg Award for B cell research LA JOLLA, CA—La Jolla Institute for Immunology (LJI) Professor Shane Crotty, Ph.D., has been awarded the 2023 AAI-BioLegend Herzenberg Award Read More
Jan 17, 2023 Research News Durable SARS-CoV-2 antibodies bind to two viral targets at once A new study led by scientists at La Jolla Institute for Immunology (LJI) shows how ideal antibodies against SARS-CoV-2 hit their marks. Read More